FUNDAMENTALS COMPLETE QUESTION 1- 100 (ACTUAL EXAM PROCTORED VIA EXAMPLIFY)
QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A
|LATEST EXAM UPDATE 2026/2027
Section One: Questions 1–100
Question 1
An 8-year-old male is brought to the clinic for a follow-up regarding his asthma management. He is
currently using a low-dose inhaled corticosteroid (ICS) daily and an as-needed short-acting beta2-agonist
(SABA). His mother reports he is waking up coughing 3 to 4 times per month and needs his SABA 3 days
a week. What is the most appropriate next step in his pharmacological management?
A. Discontinue the daily ICS and initiate a leukotriene receptor antagonist.
B. Add a long-acting beta2-agonist (LABA) to the current low-dose daily ICS.
🟢 C. Step up therapy to a medium-dose daily inhaled corticosteroid (ICS).
D. Add an oral systemic corticosteroid burst for 10 days.
🔴 RATIONALE: According to current asthma management guidelines for children aged 5-11 years,
symptoms occurring more than 2 days per week or nighttime awakenings 3-4 times per month indicate
masked or poorly controlled asthma. The appropriate action is to step up therapy. For patients already on
low-dose ICS, stepping up to a medium-dose ICS is the preferred next step before adding a LABA or
other adjunctive therapies.
Question 2
A 64-year-old female with a history of chronic open-angle glaucoma presents for a routine wellness
exam. She was recently prescribed a new topical ophthalmic medication to decrease intraocular
pressure. During the review of systems, she mentions a history of severe bradycardia and second-
degree atrioventricular block. Which of the following ophthalmic drops should be immediately evaluated
and likely discontinued?
🟢 A. Timolol
,B. Latanoprost
C. Brimonidine
D. Dorzolamide
🔴 RATIONALE: Timolol is a non-selective beta-adrenergic antagonist administered topically for
glaucoma. Significant systemic absorption can occur via the nasolacrimal duct, leading to systemic beta-
blockade. This can cause or exacerbate bradycardia, heart block, and bronchospasm. It is
contraindicated in patients with sinus bradycardia or advanced heart block. Latanoprost (prostaglandin
analog), brimonidine (alpha-2 agonist), and dorzolamide (carbonic anhydrase inhibitor) do not carry this
strong cardiac contraindication.
Question 3
An advanced practice registered nurse (APRN) is reviewing the pharmacokinetic profiles of several
newly approved medications. The APRN notes that "Drug X" is a weak organic acid with a high degree of
lipid solubility. Based on these properties, where is this drug most likely to undergo significant passive
reabsorption within the renal nephron?
A. Glomerulus
B. Proximal convoluted tubule
C. Loop of Henle
🟢 D. Distal convoluted tubule
🔴 RATIONALE: Passive reabsorption of lipid-soluble, non-ionized drugs occurs primarily in the distal
convoluted tubule and collecting ducts, where the urine becomes more concentrated. Because Drug X is
lipid-soluble, it easily diffuses across the tubular membrane back into the bloodstream. Altering the pH of
the urine in this section can ionize the drug, a process known as ion trapping, preventing its
reabsorption.
Question 4
A 45-year-old male with chronic kidney disease (CKD) Stage 3 is being treated for a deep vein
thrombosis. The clinical team is evaluating the use of low-molecular-weight heparin (LMWH) versus
unfractionated heparin (UFH). Why is UFH often preferred over LMWH, or why must LMWH doses be
,strictly adjusted, in patients with significant renal impairment?
A. UFH is primarily cleared by renal excretion, allowing for highly predictable clearance curves.
B. LMWH has a shorter half-life that requires more frequent dosing intervals in CKD patients.
🟢 C. LMWH is cleared primarily via renal excretion, increasing the risk of accumulation and bleeding in
renal impairment.
D. UFH lacks an effective reversal agent, making it safer for unpredictable renal clearance rates.
🔴 RATIONALE: Low-molecular-weight heparin (LMWH) relies heavily on renal elimination. In patients
with compromised renal function, LMWH can accumulate, significantly increasing the risk of major
bleeding complications. Unfractionated heparin (UFH) is cleared primarily via a non-renal mechanism
(reticuloendothelial system and endothelial cells) and is safer or more easily managed via partial
thromboplastin time (aPTT) monitoring in severe CKD.
Question 5
The Prescribing Safety Committee is auditing prescriptive practices regarding Controlled Substances.
Under Federal Controlled Substances Act regulations, which of the following statements is legally
accurate regarding the prescribing of Schedule II controlled substances?
A. Prescriptions may be refilled up to five times within a six-month period from the issuance date.
🟢 B. Prescriptions cannot be refilled; a new, separate prescription must be written for each
dispensation.
C. Verbal emergency prescriptions can be authorized for up to a 30-day supply without a written follow-
up.
D. Any licensed healthcare provider can prescribe Schedule II drugs regardless of state-level
collaborative agreements.
🔴 RATIONALE: Under federal law, Schedule II controlled substances have a high potential for abuse
and cannot be refilled. To obtain a subsequent supply, a provider must issue a completely new
prescription. State laws can be more restrictive but cannot override this federal prohibition on refills.
Emergency verbal orders are highly restricted, usually limited to the amount needed to treat the patient
during the emergency period, requiring a written prescription within 7 days.
, Question 6
A 52-year-old male with a history of alcohol use disorder and cirrhosis presents with acute gouty arthritis
in his right first metatarsophalangeal joint. His current hepatic panel shows elevated transaminases.
Which of the following agents is preferred for the acute management of this patient's gout flare while
minimizing hepatotoxicity risks?
A. High-dose oral Colchicine
🟢 B. Short-course oral Prednisone
C. Indomethacin
D. Febuxostat
🔴 RATIONALE: Systemic corticosteroids like Prednisone are effective and generally preferred for acute
gout flares in patients who have significant comorbidities, such as severe renal impairment or hepatic
cirrhosis, where high-dose NSAIDs (like indomethacin) or colchicine could carry elevated risks of
toxicities (e.g., gastrointestinal bleeding, hepatotoxicity, or renal decline). Febuxostat is a xanthine
oxidase inhibitor used for chronic gout prophylaxis, not acute management.
Question 7
A 29-year-old female patient who is 12 weeks pregnant presents with an clear diagnosis of severe
hyperthyroidism due to Graves' disease. Which of the following antithyroid medication regimens is
considered first-line and safest during the first trimester of pregnancy?
A. Methimazole 10 mg daily
🟢 B. Propylthiouracil (PTU) 50 mg three times daily
C. Radioactive Iodine (I-131) therapy
D. Potassium iodide solution
🔴 RATIONALE: Propylthiouracil (PTU) is preferred during the first trimester of pregnancy because
methimazole is associated with an increased risk of rare congenital malformations, specifically aplasia
cutis and choanal/esophageal atresia, which occur during organogenesis. After the first trimester, therapy
is often switched back to methimazole due to PTU's risk of severe maternal hepatotoxicity. Radioactive
iodine is completely contraindicated in pregnancy.